drugset / Trial / NCT02884817

Essential Oil+ELA, Plaque and Gingivitis

NCT02884817

Phase 4 Completed 59 enrolled University of Oslo
RandomizedParallel-groupQuadruple-blindPrevention

Summary

A commercially available mouth rinse with ethyl lauroyl arginate and essential oils claims to have enhanced antimicrobial properties as compared to the traditional essential oil products. The aim of the present study was to compare the plaque and gingivitis inhibiting effect of the commercial product containing essential oils with ethyl lauroyl arginate with one placebo and one negative control in a modified experimental gingivitis model. In three groups of healthy volunteers, experimental gingivitis was induced and monitored over 21 days, simultaneously treated with the commercial test solution, 21.6% hydro-alcohol solution and sterile water respectively. The maxillary right quadrant of each individual received mouthwash only, whereas the maxillary left quadrant was subject to both rinsing and mechanical oral hygiene. Compliance and side effects were monitored at day 7, 14, and 21. Plaque and gingivitis scores were obtained at baseline and at day 21.

Timeline

Start
2015-09
Primary completion
2015-10
Completion
2015-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Essential oils Unknown
Subject Ethyl Lauroyl Arginate Unknown

Indications